Efficacy of Natalizumab extended dosing in multiple sclerosis: a retrospective multicenter analysis

被引：0

作者：

Ryerson, L. Zhovtis ^{[1
]}

Herbert, J. ^{[1
]}

Tornatore, C. ^{[2
]}

Foley, J. ^{[3
]}

Weinstock-Guttman, B. ^{[4
]}

Kister, I. ^{[1
]}

Pandey, K. ^{[5
]}

Hojnacki, D. ^{[4
]}

Remington, G. ^{[6
]}

Frohman, T. ^{[6
]}

Major, E. ^{[7
]}

Douek, D. ^{[8
]}

Qureshi, S. ^{[6
]}

Beh, J. ^{[6
]}

Okuda, D. ^{[6
]}

Utomo, P. ^{[1
]}

Hoyt, T. ^{[3
]}

Chamot, E. ^{[9
]}

Bucello, M. ^{[4
]}

Ahsan, I. ^{[4
]}

Kolb, C. ^{[4
]}

Frohman, E. ^{[6
]}

机构：

[1] NYU, Langone Med Ctr, New York, NY USA

[2] Georgetown Univ Hosp, Neurol, Washington, DC 20007 USA

[3] Rocky Mt MS Clin, Salt Lake City, UT USA

[4] SUNY Buffalo, Neurol, Buffalo, NY 14260 USA

[5] Barnabas Hlth MS Ctr, Neurol, Livingston, NJ USA

[6] Univ Texas SW Med Ctr Dallas, Neurol, Dallas, TX 75390 USA

[7] NINDS, Bethesda, MD 20892 USA

[8] Natl Inst Allergy & Immunol, Bethesda, MD USA

[9] Univ Alabama Birmingham, Birmingham, AL USA

来源：

MULTIPLE SCLEROSIS JOURNAL | 2014年 / 20卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P287

引用

页码：194 / 195

页数：2

共 50 条

[21] The efficacy and safety of natalizumab for the treatment of multiple sclerosis in Portugal: a retrospective study
Sousa, Lvia
de Sa, Joao
Jose Sa, Maria
Cerqueira, Jose
Martins-Silva, Ana
REVISTA DE NEUROLOGIA, 2014, 59 (09) : 399 - 406
[22] Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study
Havrdova, Eva
Galetta, Steven
Hutchinson, Michael
Stefoski, Dusan
Bates, David
Polman, Chris H.
O'Connor, Paul W.
Giovannoni, Gavin
Phillips, J. Theodore
Lublin, Fred D.
Pace, Amy
Kim, Richard
Hyde, Robert
LANCET NEUROLOGY, 2009, 8 (03): : 254 - 260
[23] Extended Interval Dosing Natalizumab and impact on neuropsychological deficits in Relapsing-Remitting Multiple Sclerosis
McManus, Eileen J.
Clark, Karen M.
Frampton, Christopher
Macniven, Jamie A. B.
Schepel, Jan
MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2022, 8 (01)
[24] Exploring the effects of extended interval dosing of natalizumab and drug concentrations on brain atrophy in multiple sclerosis
Toorop, Alyssa A.
Noteboom, Samantha
Steenwijk, Martijn D.
Gravendeel, Job W.
Jasperse, Bas
Barkhof, Frederik
Strijbis, Eva M. M.
Rispens, Theo
Schoonheim, Menno M.
van Kempen, Zoe L. E.
Killestein, Joep
MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (02) : 266 - 271
[25] HEALTHCARE RESOURCE UTILIZATION AND COSTS FOR EXTENDED INTERVAL DOSING OF NATALIZUMAB IN RELAPSING REMITTING MULTIPLE SCLEROSIS
Moccia, M.
Loperto, I
Santoni, L.
Masera, S.
Carotenuto, A.
Triassi, M.
Morra, Brescia, V
Palladino, R.
VALUE IN HEALTH, 2020, 23 : S531 - S531
[26] Multiple Sclerosis Natalizumab: Efficacy with risk
Diener, H. C.
Hecht, Birgit
PSYCHOPHARMAKOTHERAPIE, 2010, 17 (02): : 106 - 108
[27] A systematic review and meta-analysis of extended interval dosing (EID) vs. standardinterval dosing (SID) of Natalizumab for multiple sclerosis patients
Rabea, Eslam Mohammed
Belal, Mohamed Mohamed
Nourelden, Anas Zakarya
Elbanna, Ashraf Hassan
Khalifa, Mahmoud Ahmed
Mahmoud, Nada H.
Zaazouee, Mohamed Sayed
NEUROLOGY, 2023, 100 (17)
[28] Personalized extended interval dosing of natalizumab in MS A prospective multicenter trial
van Kempen, Zoe L. E.
Hoogervorst, Erwin L. J.
Wattjes, Mike P.
Kalkers, Nynke F.
Mostert, Jop P.
Lissenberg-Witte, Birgit I.
de Vries, Annick
ten Brinke, Anja
van Oosten, Bob W.
Barkhof, Frederik
Teunissen, Charlotte E.
Uitdehaag, Bernard M. J.
Rispens, Theo
Killestein, Joep
NEUROLOGY, 2020, 95 (06) : E745 - E754
[29] Mri activity and extended interval of natalizumab dosing: a multicenter italian study
Clerico, M.
De Mercanti, S. F.
Signori, A.
Iudicello, M.
Cordioli, C.
Signoriello, E.
Lus, G.
Bonavita, S.
Lavorgna, L.
Maniscalco, G. T.
Curti, E.
Lorefice, L.
Cocco, E.
Nociti, V.
Mirabella, M.
Baroncini, D.
Mataluni, G.
Landi, D.
Petruzzo, M.
Lanzillo, R.
Gandoglia, I.
Laroni, A.
Frangiamore, R.
Sartori, A.
Cavalla, P.
Costantini, G.
Sormani, M. P.
Capra, R.
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 538 - 538
[30] Retrospective analysis of natalizumab switches to ublituximab in patients with relapsing multiple sclerosis
Kutz, Christen
MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1074 - 1075

← 1 2 3 4 5 →